<DOC>
	<DOCNO>NCT01235338</DOCNO>
	<brief_summary>This study examine effect co-administration SPD489 antidepressant EFFEXOR XR pharmacokinetics lisdexamfetamine , d-amphetamine , EFFEXOR XR . In addition , serial blood pressure pulse measure obtain examined ensure unexpected change vital sign follow co administration SPD489 EFFEXOR XR would impact study drug combination . The hypothesis drug drug interaction could possibly exist .</brief_summary>
	<brief_title>Co-Administration LDX ( SPD489 ) Venlafaxine XR ( EFFEXOR XR ) Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Venlafaxine Hydrochloride</mesh_term>
	<mesh_term>Lisdexamfetamine Dimesylate</mesh_term>
	<criteria>1 . Age 1845 year 2 . Subject willing comply applicable contraceptive requirement protocol : Male , Nonpregnant , nonlactating female Females must least 90 day post partum nulliparous . 3 . Female subject must negative serum beta Human Chorionic Gonadotropin ( HCG ) pregnancy test 4 . Satisfactory medical assessment 5 . Ability provide information family history hypertension . 6 . Body Mass Index ( BMI ) 18.5 30.0kg/mÂ² inclusive . 7 . Ability swallow investigational product . 1 . Current recurrent disease ( e.g. , cardiovascular , renal , liver , gastrointestinal , malignancy condition ) 2 . Current relevant previous history physical psychiatric illness . 3 . Significant illness . 4 . History significant anxiety , tension , agitation assess Investigator . 5 . History current diagnosis glaucoma . 6 . History seizure disorder ( infantile febrile seizure ) , tic disorder current diagnosis and/or know family history Tourette 's Disorder . 7 . History symptomatic cardiovascular disease , advanced arteriosclerosis , structural cardiac abnormality , cardiomyopathy , serious heart rhythm abnormality , coronary artery disease , transient ischemic attack stroke , serious cardiac problem . 8 . History control uncontrolled hypertension rest sit systolic BP &gt; 139mmHg diastolic BP &gt; 89mmHg . 9 . Known family history sudden cardiac death ventricular arrhythmia . 10 . Suicidal ideation lifetime history suicidal behavior . 11 . Consumption alcohol , Seville oranges , grapefruit , grapefruit containing product within 7 day first dose investigational product . 12 . Current use medication ( include prescription , counter [ OTC ] , herbal homeopathic preparation supplement ) exception occasional dose acetaminophen , hormonal contraceptive . 13 . History alcohol substance abuse within last year . 14 . A positive screen alcohol drug abuse . 15 . Male subject consume 21 unit alcohol per week 3 unit per day . Female subject consume 14 unit alcohol per week 2 unit per day . [ 1 alcohol unit =1 beer = 1 wine ( 5oz ) = 1 liquor ( 1.5oz ) = 0.75oz alcohol ] 16 . A positive human immunodeficiency virus ( HIV ) antibody screen , Hepatitis B surface antigen ( HBsAg ) , Hepatitis C virus ( HCV ) antibody screen . 17 . Use tobacco form ( e.g. , smoke chew ) nicotinecontaining product form ( e.g . gum , patch ) . Exusers must report stop use tobacco least 30 day prior receive first dose investigational product . 18 . Routine consumption 2 unit caffeine per day subject experience caffeine withdrawal headache . ( One caffeine unit contain follow item : one 6oz . cup coffee , two 12oz . can cola , one 12oz . cup tea , three 1oz . chocolate bar , one 8oz . serve energy drink . Decaffeinated coffee , tea , cola consider contain caffeine ) . 19 . Donation blood blood product ( e.g. , plasma platelet ) within 60 day prior receive first dose investigational product .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2013</verification_date>
</DOC>